STAT News

JULY 27, 2022

Under the terms, the generic drugmaker would pay more than $3 billion over the next 13 years to states and local governments, plus another $100 million to Native American tribes. Continue to STAT+ to read the full story… … Teva Pharmaceutical reached a national settlement agreement worth up to $4.25

Drugs 98

Drugs 98

STAT News

AUGUST 16, 2022

… Drugmakers are launching new medicines at record-high prices this year, highlighting their pricing power even as Congress moves to cut the $500 billion-plus annual bill for prescription drugs in the U.S. Continue to STAT+ to read the full story… And do keep in touch. Reuters reports. At

Sales 98

Sales Drugs Manufacturing Medicine 98

pharmaphorum

FEBRUARY 3, 2022

At the time the line was that the 64-year-old was retiring, although STAT reported that he had been pushed out by Biogen CEO Michel Vounatsos. On the plus side, Voyager agreed a $630 million alliance with Pfizer in October to give the big pharma access to its TRACER AAV vector technology, which aims to improve the safety of gene therapies.

Gene Therapy 97

Gene Therapy Gene Clinical Trials Clinical Trials 97

STAT News

AUGUST 23, 2022

Meanwhile, do keep in touch — we enjoy secret dossiers and saucy tips … Pfizer and BioNTech asked the Food and Drug Administration to clear use of a Covid-19 shot modified to target the newest versions of the Omicron variant , STAT says. The Pfizer-BioNTech booster shot targets the original coronavirus plus the BA.4

Vaccination 98

Vaccination Vaccine Production Drugs 98

The Pharma Data

JANUARY 15, 2021

1 Recommended first-line treatment for HER2 positive advanced or metastatic gastric cancer is combination chemotherapy plus trastuzumab, an anti-HER2 medicine, which has been shown to improve survival outcomes when added to chemotherapy. Cancer Stat Facts: Stomach Cancer. Targeted Therapies for Stomach Cancer. October 2020.

Medicine 52

Medicine Trials Antibody HR 52

The Pharma Data

JUNE 18, 2021

“VENCLYXTO has proven incremental overall survival in treating newly diagnosed AML in patients who are ineligible for intensive chemotherapy when treated with VENCLYXTO plus azacitidine compared to those treated with azacitidine alone,” said Mohamed Zaki , M.D., months for the VENCLYXTO plus azacitidine arm versus 9.6

Trials 40

Trials Clinical Trials Clinical Trials Medicine 40

The Pharma Data

APRIL 28, 2021

months for the VENCLYXTO plus azacitidine arm versus 9.6 months in the placebo plus azacitidine arm. The study also met secondary endpoints, with the VENCLYXTO plus azacitidine arm resulting in a CR rate of 36.7 percent in the placebo plus azacitidine arm and a composite complete remission rate (CR + CRi) of 66.4

Trials 40

Trials Medicine Clinical Trials Clinical Trials 40

The Pharma Data

JUNE 18, 2021

Ibrutinib plus venetoclax is an investigational fixed-duration combination. ” This data builds on previously reported results from the Minimal Residual Disease (MRD) cohort where undetectable uMRD was achieved in over two-thirds of patients with 12 cycles of ibrutinib plus venetoclax, and 30-month PFS rates were ?95%

Medicine 40

Medicine Production FDA Approval Trials 40

The Pharma Data

MARCH 31, 2023

Exploratory analyses included EFS by surgical approach, EFS by extent or completeness of resection, and EFS and pathologic complete response (pCR) by a four-gene ( CD8A, CD274, STAT-1, LAG-3 ) inflammatory signature score derived from RNA sequencing of baseline tumor samples.

Trials 40

Trials HR Medicine Development 40

Pharma Marketing Network

NOVEMBER 4, 2020

Tom (AC): So I did an interesting stat from Scott Galloway who does the Prof G podcast. Tom (AC): Yes so many interesting things in this. RJ (PMN): Oh. I love him. Tom (AC): Yeah.

Branding 52

Branding Marketing Regulation Production 52

The Pharma Data

MAY 16, 2021

I don’t need to give you the stats on why we need to stay flexible and loose, especially as we get older. PLUS instantly download the digital versions and bonuses absolutely free. PLUS instantly download the digital versions and bonuses absolutely free. PLUS instantly download the digital versions and bonuses absolutely free.

Production 52

Production Containment Hormones Vaccination 52

The Pharma Data

JUNE 18, 2021

Cancer Stat Facts: Leukemia – Chronic Lymphocytic Leukemia (CLL). AbbVie undertakes no obligation to release publicly any revisions to forward-looking statements as a result of subsequent events or developments, except as required by law. References. 1 IMS Database [Data on File]. 2 National Cancer Institute. Accessed May 2021.

Medicine 52

Medicine Production FDA Approval Trials 52

The Pharma Data

DECEMBER 15, 2020

CUE-300 Series Immuno-STATs may offer autoimmune patients therapeutic benefits without compromising their immune systems. Anti-CD40L Antibody. Patient Recruitment.

Clinical Trials 52

Clinical Trials Clinical Trials Antibody Trials 52

WCG Clinical

JULY 17, 2023

So part of the issue is we do a lot of trials that are standard of care, plus procedures that are research only. How do these stats resonate with you and the work you’re doing? We have seen more data points and we have seen longer trials, lengthier trials with more procedures, and this has impacted our startup times.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Research 52

The Pharma Data

OCTOBER 26, 2020

Atezolizumab plus bevacizumab and chemotherapy in non-small-cell lung cancer (IMpower150): key subgroup analyses of patients with EGFR mutations or baseline liver metastases in a randomised, open label phase 3 trial. . Prognostic Significance of Liver Metastasis in Durvalumab-Treated Lung Cancer Patients. .

Vaccination 52

Vaccination Vaccine Trials Containment 52

XTalks

SEPTEMBER 14, 2020

On the plus side of the ledger, the pandemic has put downward pressure on urban rental properties, with rents actually dropping for the first time in decades as Airbnb owners in particular can no longer count on temporary visitors to fill their condos. More than 30 countries, including Canada, have pledged $8.8

Vaccination 92

Vaccination Vaccine Antibody Life Science 92